Infection Control Market

Global Infection Control Market Size (2023 to 2028)

The global infection control market size is forecasted to be worth USD 88.1 billion by 2028 from USD 49.1 billion in 2023, registering a CAGR of 12.4% from 2023 to 2028.

Global Infection Control Market Share Insights:

• Based on products and services, the cleaning and disinfection segment dominated the infection control market in 2022.
• Based on the end-user, the hospital segment led the infection control market and accounted for a global market share of 32.8% in 2022.
• North America captured a global market share of 36.8% in 2022.
• The European market held a notable share of the global market in 2022.

Impact of the COVID-19 pandemic on the infection control market:

The outbreak of Covid-19 in 2020 led to increased awareness of hand and personal hygiene. It is reported by WHO that almost 70% of infections can be avoided by maintaining good hand hygiene. Hand washing became a critical activity during Covid-19 which led to increased demand for soaps, sanitizer, and other hygiene products. There was a great surge in demand for hand hygiene products and industries witnessed a huge demand and sales. The impact of Covid-19 also led to increased use of PPE kits, masks, gowns, and face shields among healthcare providers and the public to safeguard themselves from the virus and resulted in increased production and demand. The importance of surface disinfection among people increased during the period of Covid-19 surface disinfectant solutions and wipes. The use of these products became a regular practice in healthcare and other settings to prevent infection. Along with surface disinfection, Covid-19 acted as a trigger in research and developments to find newer technologies to combat the spread of the virus.

MARKET DRIVERS:

The growing incidence of hospital-acquired infections (HAI) is one of the major factors driving the growth of the infection control market. Hospital-acquired infections create a major threat to hospitals and the healthcare system. These infections are found to be difficult to treat because of resistance to antibiotics and other treatments. According to WHO, 1 in 10 cases of HAIs causes death. These increasing cases of hospital-acquired infections are due to poor compliance with policies and guidelines for handling patients and infected equipment. Poor adherence to this causes an increased risk of death. Therefore, to combat this, healthcare facilities took measures, leading to demand in Infection Control Market for products and services.

The growing awareness about prevention measures and guidelines further fuels the growth rate of the infection control market. Post-COVID-19 pandemic, there is an increased awareness regarding sanitation and controlling infection among doctors, healthcare professionals, and the public. This heightened sense of responsibility toward infection management had led to an increased use of products and services that aid in infection control. With the outbreak of Covid-19, knowledge about sanitation and good hygiene increased among the public, and hospitals and healthcare facilities upgraded and made stringent protocols for controlling infections leading to nosocomial infections.

The growing patient population with chronic diseases contributes to the infection control market growth. Due to drastic changes in lifestyle and habits, there is a surge in chronic diseases such as diabetes and high blood sugar, leading to weakened immune systems, making them susceptible to infections easily. People with chronic illnesses visiting hospitals and healthcare facilities make them more prone to nosocomial infection than others with uncompromised immune systems. As chronic conditions increase, the demand for infection control measures like vaccination drives, sterilization, personnel infection management, and hygiene products and solutions will increase.

The growing healthcare expenditure favors the infection control market growth. There is an increase in spending capacity toward healthcare and hospitals, including in developed and developing countries. This has a huge investment in infection control strategies in hospitals and healthcare facilities. Funding through the government and organizations for infection prevention solutions led to the expansion of the market.

MARKET RESTRAINTS:

The adverse environmental impact of using infection control products and solutions majorly hampers the market growth. With the increasing use of disinfectants and solutions, there is an increasing environmental impact. Disinfectants destroy pathogens but also contribute to the release of harmful toxic fumes which irritate the respiratory system. A lot of medical waste like safety gear, PPEs suits, hazmat suits, and masks which are nondegradable creates plastic waste which gets into the ecosystem, like rivers and sea and chokes the flora and fauna, creating imbalance. This crisis of biomedical waste is deepening and creating a major concern about how more eco-friendly materials can be used. The high cost of infection control products and services further hinders the infection control market growth. Infection control products and services involve high costs, which limits their widespread utilization, especially in developing areas, where the investment for infection control is not adequate and it leads to compromising situations where patients and staff members have a high probability of getting infected.

Limited awareness and understanding of infection control practices among healthcare professionals and the general population and insufficient funding and budget constraints, particularly in healthcare facilities with limited resources limit the growth rate of the infection control market. Inadequate staffing levels and shortage of trained infection control personnel, lack of standardized guidelines and protocols across healthcare settings and limited access to infection control education and training programs further impede the market growth.

REPORT COVERAGE:

This research report on the global infection control market has been segmented and sub-segmented based on Products and Services, end-user, and regions.

Infection Control Market – By Products and Services:

• Cleaning and Disinfection Products
• Sterilization Products and Services
• Endoscope Reprocessing Products
• Protective Equipment
• Others

The cleaning and disinfection products segment is estimated to account for the largest share among all segments based on the products and services and is expected to register a stable CAGR during the forecast period. The growing awareness among people about the effects of deadly infections primarily drives the growth of the cleaning and disinfection products segment. The growing emphasis on maintaining clean and hygienic environments in healthcare facilities, rising awareness of the importance of proper cleaning and disinfection practices to prevent infections and concern over healthcare-associated infections (HAIs) and the need for effective disinfection solutions propel the cleaning and disinfection products segment in the global market.

The sterilization products segment is predicted to be the second largest among all and is expected to grow at a decent CAGR from 2023 to 2028. Stringent regulations and guidelines mandating sterilization practices in healthcare settings, rising demand for sterilization technologies to prevent the transmission of infections and advancements in sterilization techniques and increasing adoption of automated sterilization systems further fuel the growth rate of the sterilization products segment in the worldwide market.

The protective equipment segment is anticipated to account for a substantial share of the global market during the forecast period. The growing focus on infection prevention measures in healthcare settings, increasing awareness of personal protective equipment (PPE) importance in preventing the spread of infections and surge in demand for PPE due to the COVID-19 pandemic drive the growth of the protective equipment segment in the global market.

The endoscope reprocessing segment is expected to grow significantly during the forecast period. Factors such as the growing prevalence of endoscope-related infections and the need for proper reprocessing, the rising focus on ensuring endoscope safety and reducing the risk of cross-contamination and advancements in endoscope reprocessing technologies and guidelines drive the growth of the endoscope reprocessing segment in the global market.

Infection Control Market – By End-User:

• Hospitals and clinics
• Medical device companies
• Pharmaceutical companies
• Life sciences companies
• Food Industry
• Others

Based on the end-user, the hospitals and clinics held the largest share of the global infection control market in 2022 and the domination of the segment is likely to continue during the forecast period. The rising awareness about healthcare-associated infections (HAIs), growing emphasis on infection prevention and control measures, stringent regulations and guidelines for infection control in healthcare settings and increasing demand for effective disinfection and sterilization products majorly drive the growth of the hospitals and clinics segment in the worldwide market.

The medical device companies segment is anticipated to account for a notable share of the global market during the forecast period owing to the growing focus on patient safety and infection control in medical devices, stringent regulations and standards for sterilization and disinfection of medical devices and rising demand for single-use and disposable medical devices.

The pharmaceutical companies segment is the next biggest segment in the worldwide market during the forecast period. Factors such as the growing need for aseptic manufacturing processes in pharmaceutical production, focus on maintaining product quality and preventing contamination and compliance with regulatory requirements for cleanrooms and controlled environments.

Infection Control Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Regionally, the Asia Pacific region is expected to showcase the highest CAGR in the global market during the forecast period among all the regions. Rapidly growing healthcare infrastructure, increasing healthcare spending and the growing awareness about the importance of infection control in healthcare settings drive the infection control market in North America. The presence of a large population, high prevalence of infectious diseases and rapid adoption of advanced medical devices and technologies further fuel the growth rate of the APAC market. Countries such as India and China have the highest population and population growth worldwide, which majorly regulates the market growth in this region. The developing countries are now focusing on hygiene, and thus they are providing more infection control products to maintain overall hygiene. China is the largest manufacturer and exporter of PPE kits in the world.

North America held the largest share of the global infection control market in 2022 and the domination of the North American region is expected to continue throughout the forecast period owing to the strict regulatory requirements and guidelines for infection control in healthcare facilities. Factors such as high healthcare expenditure, the presence of advanced healthcare infrastructure, growing awareness about HAIs and the importance of infection prevention and rising demand for advanced sterilization and disinfection products further drive the growth of the North American market. The U.S. is expected to account for the major share of the North American market during the forecast period.

The European region had the second-largest share of the global market in 2022 and is expected to register a notable CAGR during the forecast period owing to the stringent infection control regulations and guidelines implemented by regulatory authorities. The growing prevalence of HAIs and focus on patient safety, well-established healthcare systems with emphasis on infection prevention and control and technological advancements in sterilization and disinfection methods contribute to the growth of the Europe market.

KEY MARKET PARTICIPANTS:

Some of the prominent companies dominating the global infection control market analyzed in this report are 3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group.

RECENT HAPPENINGS IN THIS MARKET:

• In December 2018, Holchem Group Limited was acquired by Ecolab. (UK). Echolab's hygiene and cleaning product and service range for the food and beverage, food service, and hospitality sectors was improved due to this acquisition.
• In November 2018, Omnia S.p.A. was acquired by Cantel Medical. (Italy). Cantel's position in the dental infection prevention market in Italy and other European countries was strengthened by the acquisition of Omnia, a dental surgical consumables business.
• In September 2018, Getinge (Sweden) introduced the S-8668T Washer Disinfector. (a new addition to the Getinge 86 Series).
• In February 2017, Getinge (Sweden) and Ultra Clean Systems, Inc. (the US) signed an agreement under which Getinge would sell Ultra Clean Systems' hospital-grade ultrasonic cleaning devices, accessories, and detergents to healthcare facilities in the United States and Canada.